Surge In Spinal Cord Injuries Driving Growth In The Kyphoscoliosis Treatment Market Emerges as a Core Driver of the Kyphoscoliosis Treatment Market in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts

What Is the Expected CAGR for the Kyphoscoliosis Treatment Market Through 2025?
The market size for kyphoscoliosis treatment has seen a significant increase recently. The market, which is projected to increase from $3.08 billion in 2024 to $3.27 billion in 2025, expects a compound annual growth rate (CAGR) of 6.3%. The expansion in the historical period is related to the exploration of regenerative medicine, contributions from genetic research, the use of telemedicine and remote monitoring, and progress in rehabilitation programs.

What's the Projected Size of the Global Kyphoscoliosis Treatment Market by 2029?
In the coming years, robust expansion is anticipated in the kyphoscoliosis treatment market, with predictions of it escalating to $4.1 billion in 2029, witnessing a compound annual growth rate (CAGR) of 5.8%. Increase during the outlook period can be owed to individualized treatment methodologies, the breadth of biomechanical studies, the integration of telehealth services and remote supervision, and persistent genetic investigation. The anticipation period is likely to witness state-of-the-art surgical procedures, novel bracing techniques, personalized treatment blueprints, the incorporation of 3D printing, and breakthroughs in pain management as the main trends.

View the full report here:
https://www.thebusinessresearchcompany.com/report/kyphoscoliosis-treatment-global-market-report

Top Growth Drivers in the Kyphoscoliosis Treatment Industry: What's Accelerating the Market?
The escalating incidence of spinal cord injuries is projected to stimulate kyphoscoliosis treatment market growth. Such injuries involve trauma, harm or damage to various components of the spine, including bones, intervertebral discs, ligaments, muscles, nerves, and other support structures. These injuries result in kyphoscoliosis and subsequently induce modifications in spinal alignment. Comprehensive strategies, such as orthopedic evaluation, physical therapy, bracing, potential surgery, pain control, and a multifaceted healthcare team emphasising patient education and personalised care plans are adopted for treating kyphoscoliosis linked to spinal cord injuries. For example, as reported by the Alabama Department of Public Health, a state agency based in the US, The ATR documented 3,817 neurological injuries involving the brain and spinal cord in 2022, in contrast to 4,734 cases reported in 2021. As a result, the escalating number of spinal cord injuries is contributing to the expansion of the kyphoscoliosis treatment market. The kyphoscoliosis treatment market is expected to flourish due to growing telemedicine usage. Telemedicine, a sector of healthcare involving the employment of telecommunications technology such as video conferencing, phone calls, and digital messaging, facilitates remote clinical services for patients. It enables people to consult orthopedic specialists and spine surgeons from a distance, an invaluable service for individuals struggling with physical travel constraints due to kyphoscoliosis. For instance, a survey conducted by Rock Health, a non-profit corporation based in the US, in 2022, revealed that 80% of respondents admitted to using telemedicine at least once in their lives. This revealed an 8 percentage point increase from the 72% in 2021, indicating telemedicine's contribution to the growth of the healthcare transportation service market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13292&type=smp

What Trends Will Shape the Kyphoscoliosis Treatment Market Through 2029 and Beyond?
Leading entities in the kyphoscoliosis treatment market are introducing groundbreaking products such as the MARVEL growing rod system, formulated especially for early-onset scoliosis. This system is a posterior stabilizing rod that can be surgically inserted and manually extended using hand-operated mechanical action. For instance, Globus Medical Inc., a medical device company based in the US, unveiled the MARVEL growing rod system in July 2023. Designed to assist patients below 10 years suffering from early-onset scoliosis, this system is intended to not only help achieve but also maintain correction all the while allowing consistent growth through minimally invasive distraction. Offering significant diversion, direct tactile feedback, and automated locking, it ensures reliable growth. The MARVEL Growing Rod System, a pioneering product, is expected to contribute significantly to the future growth of the industry.

What Are the Main Segments in the Kyphoscoliosis Treatment Market?
The kyphoscoliosis treatment market covered in this report is segmented -

1) By Type: Postural Kyphosis, Scheuermann's Kyphosis, Congenital Kyphosis
2) By Treatment: Medications, Surgery And Bracing
3) By End-User: Hospital, Clinics, Ambulatory Surgical Centers

Subsegments:
1) By Postural Kyphosis: Adolescent Postural Kyphosis, Adult Postural Kyphosis
2) By Scheuermann's Kyphosis: Adolescent Scheuermann's Kyphosis, Adult Scheuermann's Kyphosis
3) By Congenital Kyphosis: Type I Congenital Kyphosis, Type II Congenital Kyphosis, Other Congenital Forms

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13292&type=smp

Which Top Companies are Driving Growth in the Kyphoscoliosis Treatment Market?
Major companies operating in the kyphoscoliosis treatment market report are Johnson & Johnson Services Inc., Aspen Medical Products LLC, Medtronic PLC, Stryker Corporation, Milwaukee Brace Company, Zimmer Biomet Holdings Inc., Perrigo Company PLC, Teva Pharmaceuticals Inc., B. Braun Melsungen Aktiengesellschaft, Aurobindo Pharma Limited, Integra LifeSciences Ltd., NuVasive Inc., DJO Global Inc., Globus Medical Inc., Boston Orthotics & Prosthetics, Ossur hf., Aesculap Inc., DeRoyal Industries Inc., MicroPort Scientific Corp., Alphatec Holdings Inc., Trulife Ltd., Ottobock SE & Co. KGaA, Orthofix Holdings Inc., OrthoPediatrics Corp., Proteor S.A., Orthomerica Products Inc., Breg Inc., Innomed Inc., Restorative Care of America Inc., Spinal Elements Inc.

Which Regions Will Dominate the Kyphoscoliosis Treatment Market Through 2029?
North America was the largest region in the kyphoscoliosis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the kyphoscoliosis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13292

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.